These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2218924)

  • 21. [Treatment of membranous glomerulonephritis].
    Stavskaia VV; Riabov SI
    Ter Arkh; 1985; 57(6):74-8. PubMed ID: 4071419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N
    Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
    [No Abstract]   [Full Text] [Related]  

  • 23. [The action spectrum of cytostatics in the management of glomerulonephritis].
    Kakuk G; Szabó J; Löcsey L; Szabó T
    Z Urol Nephrol; 1977 Aug; 70(8):595-602. PubMed ID: 919806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinico-laboratory pattern and effectiveness of glucocorticoid therapy of patients with primary diffuse mesangioproliferative glomerulonephritis].
    Diadyk AI; Dikshteĭn EA; Vasilenko IV; Siniachenko OV; Kobets VG
    Ter Arkh; 1987; 59(8):35-7. PubMed ID: 3686443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [State of the blood prekallikrein-kallikrein system in patients with glomerulonephritis as affected by pathogenetic therapy].
    Petrun' NM; Pyrig LA; Krimkevich EI
    Ter Arkh; 1985; 57(6):84-6. PubMed ID: 3852551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N
    Vutr Boles; 1986; 25(2):21-5. PubMed ID: 3716373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
    Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
    Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
    Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prediction of accelerated progression of chronic glomerulonephritis basing on clinical and histomorphological data].
    Ratner MIa; Stenina II; Fedorova ND
    Ter Arkh; 1999; 71(6):27-30. PubMed ID: 10420451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Systemic enzyme therapy in chronic glomerulonephritis].
    Siniachenko OV; Kovalenko VN; Mukhin IV; Ignatenko GA; Terzov AI
    Ter Arkh; 2000; 72(2):46-8. PubMed ID: 10717926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors].
    Belovezhdov N
    Vutr Boles; 1985; 24(1):40-9. PubMed ID: 4024608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of nephrotic-type chronic glomerulonephritis with Sandimmun (cyclosporin A)].
    Mukhin NA; Tareeva IE; Krasnova TN; Shilov EM; Miroshnichenko NG
    Ter Arkh; 1995; 67(8):13-5. PubMed ID: 7482320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative evaluation of the clinical course and dynamics of the morphological changes in chronic glomerulonephritis].
    Tov NL; Valentik MF; Vlazneva VA; Kagalovskaia IM; Nesina IA
    Ter Arkh; 1986; 58(8):10-3. PubMed ID: 3764748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasmapheresis in the combined therapy of progressive forms of glomerulonephritis].
    Moskaleva ES; Ignatova MS; Korneeva VA; Muromtsev IuV; Tsvetkova EI; Parubinovskaia NM; Kharina EA; Katysheva OV; Krivonos AV
    Ter Arkh; 1994; 66(6):42-5. PubMed ID: 7940367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Survival of patients with diffuse glomerulonephritis in disseminated lupus erythematosus treated with a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N; Dimitrova V
    Vutr Boles; 1987; 26(1):21-7. PubMed ID: 3590722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-morphologic analysis of compensatory and adaptive processes of the kidneys in chronic glomerulonephritis].
    Zufarov AK
    Ter Arkh; 1989; 61(6):73-5. PubMed ID: 2799721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.